Tscan Therapeutics Inc (TCRX)

Nov 21, 2024

TScan issues stock in loan conversion - Investing.com

Nov 21, 2024

Nov 21, 2024

LMR Partners LLP Reduces Stock Position in TScan Therapeutics, Inc. (NASDAQ:TCRX) - MarketBeat

Nov 21, 2024

Nov 20, 2024

Tscan therapeutics sees $4,113 stock purchase by Lynx1 capital - Investing.com India

Nov 20, 2024

Nov 20, 2024

TScan Therapeutics (TCRX) Soars 7.6%: Is Further Upside Left in the Stock? - MSN

Nov 20, 2024

Nov 20, 2024

TScan Therapeutics, Inc. (TCRX) Reports Q3 Loss, Misses Revenue Estimates - MSN

Nov 20, 2024

Nov 19, 2024

Lynx1 Capital Management LP Increases Stake in TScan Therapeutics Inc - GuruFocus.com

Nov 19, 2024

Nov 19, 2024

TScan Therapeutics (NASDAQ:TCRX) Earns “Buy” Rating from HC Wainwright - Defense World

Nov 19, 2024

Nov 16, 2024

FY2024 Earnings Estimate for TCRX Issued By Lifesci Capital - Defense World

Nov 16, 2024

Nov 16, 2024

FY2024 EPS Estimate for TScan Therapeutics Lifted by Analyst - Defense World

Nov 16, 2024

Nov 15, 2024

TScan Therapeutics (NASDAQ:TCRX) Earns "Buy" Rating from HC Wainwright - MarketBeat

Nov 15, 2024

Nov 15, 2024

Wedbush Research Analysts Boost Earnings Estimates for TCRX - MarketBeat

Nov 15, 2024

Nov 14, 2024

TScan Therapeutics Inc (TCRX) Quarterly 10-Q Report - Quartzy

Nov 14, 2024

Nov 14, 2024

Wedbush Has Positive Forecast for TCRX FY2028 Earnings - MarketBeat

Nov 14, 2024

Nov 14, 2024

TScan Therapeutics' SWOT analysis: biotech stock poised for key catalysts By Investing.com - Investing.com Nigeria

Nov 14, 2024

Nov 14, 2024

TScan Therapeutics' SWOT analysis: biotech stock poised for key catalysts - Investing.com India

Nov 14, 2024

Nov 14, 2024

TScan Therapeutics Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

Nov 14, 2024

Nov 14, 2024

Needham & Company LLC Reaffirms “Buy” Rating for TScan Therapeutics (NASDAQ:TCRX) - Defense World

Nov 14, 2024

Nov 13, 2024

TScan Therapeutics Reports Q3 2024 Financial Results - TipRanks

Nov 13, 2024

Nov 12, 2024

Tscan Therapeutics earnings beat by $0.06, revenue fell short of estimates - Investing.com Canada

Nov 12, 2024

Nov 12, 2024

TScan Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update - The Manila Times

Nov 12, 2024

Nov 12, 2024

TScan Reports Zero Relapses in Key Trial Despite 74% Revenue Drop; $271M Cash Runway | TCRX Stock News - StockTitan

Nov 12, 2024

Nov 07, 2024

New Blood Cancer Treatment Shows Continued Response - Streetwise Reports

Nov 07, 2024

Nov 07, 2024

Tscan Therapeutics Inc’s (TCRX) 7.56% Increase Justifies A Second Look - Stocks Register

Nov 07, 2024

Nov 06, 2024

TScan Therapeutics' (TCRX) "Buy" Rating Reaffirmed at Needham & Company LLC - MarketBeat

Nov 06, 2024

Nov 06, 2024

Demystifying TScan Therapeutics: Insights From 4 Analyst Reviews - Benzinga

Nov 06, 2024

Nov 06, 2024

Does TScan Therapeutics (NASDAQ:TCRX) Have A Healthy Balance Sheet? - Simply Wall St

Nov 06, 2024

Nov 06, 2024

TScan Therapeutics' SWOT analysis: innovative therapy stock faces pivotal year - Investing.com Australia

Nov 06, 2024

Nov 05, 2024

TScan Therapeutics Announces Upcoming Oral Presentation of - GlobeNewswire

Nov 05, 2024

Nov 05, 2024

TScan's Blood Cancer Trial Shows Zero Relapses: Breakthrough Phase 1 Results | TCRX Stock News - StockTitan

Nov 05, 2024

Nov 04, 2024

Waltham cancer biotech adds to real estate footprint - The Business Journals

Nov 04, 2024

Nov 04, 2024

TScan Therapeutics (NASDAQ:TCRX) Enters Second Amendment for Lease Agreement to Expand Operations at Winter Street FacilityOn October 28, 2024, TScan Therapeutics, Inc. finalized a second amendment to its lease agreement with PPF OFF 828-83 - Defense World

Nov 04, 2024

Nov 02, 2024

TScan expands Waltham facility with additional lease - Investing.com India

Nov 02, 2024

Nov 01, 2024

TScan expands Waltham facility with additional lease By Investing.com - Investing.com UK

Nov 01, 2024

Oct 26, 2024

Head to Head Review: ProKidney (NASDAQ:PROK) vs. TScan Therapeutics (NASDAQ:TCRX) - Defense World

Oct 26, 2024

Oct 21, 2024

The Manufacturers Life Insurance Company Invests $90,000 in TScan Therapeutics, Inc. (NASDAQ:TCRX) - Defense World

Oct 21, 2024

Oct 18, 2024

Where are the Opportunities in (TCRX) - Stock Traders Daily

Oct 18, 2024

Oct 15, 2024

BTIG Initiates Coverage of TScan Therapeutics (TCRX) with Buy Recommendation - MSN

Oct 15, 2024

Oct 08, 2024

Bank of Montreal Can Acquires Shares of 120,454 TScan Therapeutics, Inc. (NASDAQ:TCRX) - MarketBeat

Oct 08, 2024

Oct 08, 2024

Bank of Montreal Can Invests $749,000 in TScan Therapeutics, Inc. (NASDAQ:TCRX) - MarketBeat

Oct 08, 2024

Oct 07, 2024

(TCRX) On The My Stocks Page - Stock Traders Daily

Oct 07, 2024

Oct 06, 2024

TScan Therapeutics, Inc. (NASDAQ:TCRX) Stock Position Lifted by Marshall Wace LLP - MarketBeat

Oct 06, 2024

Oct 05, 2024

American Century Companies Inc. Increases Position in TScan Therapeutics, Inc. (NASDAQ:TCRX) - Defense World

Oct 05, 2024

Oct 04, 2024

TCRXTScan Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Oct 04, 2024

Oct 04, 2024

TScan Therapeutics Announces Upcoming Presentations at the - GlobeNewswire

Oct 04, 2024

Oct 04, 2024

TScan Therapeutics Announces Upcoming Presentations at the Society for Immunotherapy of Cancer 39th Annual Meeting - StockTitan

Oct 04, 2024

Oct 04, 2024

Reviewing TScan Therapeutics (NASDAQ:TCRX) and Sorrento Therapeutics (OTCMKTS:SRNEQ) - Defense World

Oct 04, 2024

Oct 01, 2024

Tscan Therapeutics Inc [TCRX] Stock bought by Insider Klencke Barbara for $26450.0 - Knox Daily

Oct 01, 2024

Oct 01, 2024

Was there any good news for Tscan Therapeutics Inc (TCRX) stock in the last session? - US Post News

Oct 01, 2024

Oct 01, 2024

Market Momentum Report: Tscan Therapeutics Inc (TCRX)’s Negative Close at 4.98 - The Dwinnex

Oct 01, 2024